Consolidated Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7711657

Concept 2018-03-01 to
2019-02-28
As at
2019-02-28
2018-03-01 to
2019-02-28
2017-03-01 to
2018-02-28
As at
2018-02-28
2017-03-01 to
2018-02-28
As at
2017-02-28
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
21,172,000,000 JPY
25,673,000,000 JPY
20,822,000,000 JPY
27,694,000,000 JPY
Depreciation
5,742,000,000 JPY
6,005,000,000 JPY
Impairment losses
138,000,000 JPY
1,023,000,000 JPY
Increase (decrease) in allowance for doubtful accounts
64,000,000 JPY
-71,000,000 JPY
Interest and dividend income
-1,563,000,000 JPY
-1,217,000,000 JPY
Interest expenses
19,000,000 JPY
32,000,000 JPY
Increase (decrease) in retirement benefit liability
227,000,000 JPY
284,000,000 JPY
Increase (decrease) in provision for bonuses
-17,000,000 JPY
-13,000,000 JPY
Foreign exchange losses (gains)
126,000,000 JPY
69,000,000 JPY
Share of loss (profit) of entities accounted for using equity method
-619,000,000 JPY
-129,000,000 JPY
Decrease (increase) in trade receivables
-5,310,000,000 JPY
667,000,000 JPY
Subtotal
23,665,000,000 JPY
36,180,000,000 JPY
Decrease (increase) in inventories
1,310,000,000 JPY
485,000,000 JPY
Income taxes paid
-9,339,000,000 JPY
-6,935,000,000 JPY
Net cash provided by (used in) operating activities
15,772,000,000 JPY
30,453,000,000 JPY
Increase (decrease) in trade payables
649,000,000 JPY
-316,000,000 JPY
Other, net
184,000,000 JPY
412,000,000 JPY
Interest and dividends received
1,465,000,000 JPY
1,240,000,000 JPY
Interest paid
-19,000,000 JPY
-32,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-3,626,000,000 JPY
-3,131,000,000 JPY
Proceeds from sale of property, plant and equipment
291,000,000 JPY
82,000,000 JPY
Purchase of investment securities
-353,000,000 JPY
-691,000,000 JPY
Net cash provided by (used in) investing activities
-39,302,000,000 JPY
-1,378,000,000 JPY
Proceeds from collection of loans receivable
6,000,000 JPY
6,000,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-6,176,000,000 JPY
-2,000,000 JPY
Dividends paid
-6,882,000,000 JPY
-6,855,000,000 JPY
Dividends paid to non-controlling interests
-68,000,000 JPY
-59,000,000 JPY
Repayments of long-term borrowings
-71,000,000 JPY
-71,000,000 JPY
Net cash provided by (used in) financing activities
-13,347,000,000 JPY
-7,153,000,000 JPY
Other, net
-48,000,000 JPY
-64,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-908,000,000 JPY
-963,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-37,786,000,000 JPY
20,959,000,000 JPY
Cash and cash equivalents
88,782,000,000 JPY
126,569,000,000 JPY
105,610,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.